Search Results

37 results

  1. CORESTA Meeting, Agronomy/Phytopathology, 2019, Victoria Falls, AP Sustainability Forum

    Agro-Phyto Sustainability Forum

    WILDE L.(1); PRIBIC V.(2); EVANS W.(3); ROYO E.(4); BARGIACCHI E.(5); COLARD S.(6)
    (1) twentyfifty Ltd, Frome, U.K.; (2) JT International S.A., Geneva, Switzerland; (3) Imperial Tobacco Limited, Durban, South Africa; (4) Philip Morris International, Cape Town, South Africa; (5) Consortium INSTM, Firenze, Italy; (6) CORESTA, Paris, France
    In 2015, the United Nations published 17 sustainable development goals and their corresponding targets to be achieved by 2030. Like other sectors, the tobacco and alternative product sectors are likely to impact most of the goals. Consequently, it is ...
  2. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 49

    The CORESTA in vitro test battery for combustible tobacco products: update from the 2004 Rationale and Strategy Report

    LEE K.M.(1); JORDAN K.G.(2); WIECZOREK R.(3); MOENNIKES O.(4); CLEMENTS J.(5); CROOKS I.(6); HASHIZUME T.(7); MILLER J.(8); WEBER E.(9); YOSHINO K.(7)
    (1) Altria Client Services, Richmond, VA, U.S.A.; (2) RAI Services Company, Winston-Salem, NC, U.S.A.; (3) Imperial Brands, Reemtsma Cigarettenfabriken GmbH, Hamburg, Germany; (4) PMI R&D, Philip Morris Products S.A., Neuchâtel, Switzerland; (5) Covance Laboratories Ltd, Harrogate, U.K.; (6) British American Tobacco (Investments) Ltd, R&D, Southampton, U.K.; (7) Japan Tobacco Inc., Yokohama, Kanagawa, Japan; (8) JT International SA, Geneva, Switzerland; (9) Ökolab, Vienna, Austria
    In 2004, the CORESTA In Vitro Toxicity Task Force issued a rationale and strategy report, commonly known as “the CORESTA in vitro test battery guideline”. The goals of this guideline were to: 1) develop the rationale and strategy for conducting in vitro ...
  3. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 58

    A consortium approach for consumer-reported outcome measures to assess tobacco- and nicotine-containing products

    ACQUADRO C.(1) on behalf of the CORESTA CROM Task Force: AYALA-FIERRO F.(2); BLACK R.(3); CAHOURS X.(4); CHREA C.(5); CURTIN G.(6); GILES L.(7); McCAFFREY S.(3); PARK C.H.(8); PRASAD K.(9); SHERWOOD N.(10); SHIFFMAN S.(11); SMITH J.(6); SPIES E.(5)
    (1) Mapi Research Trust, Lyon, France; (2) ITG Brands, Greensboro, NC, U.S.A.; (3) Altria Client Services, Richmond, VA, U.S.A.; (4) SEITA - Imperial Brands, Paris, France; (5) Philip Morris Products S.A., Neûchatel, Switzerland; (6) RAIS, Winston-Salem, NC, U.S.A.; (7) JT Int'l SA, Genève, Switzerland; (8) KT&G Research Institute, Daejeon, Republic of Korea; (9) British American Tobacco, Southampton, U.K.; (10) Neil Sherwood Consulting, Commugny, Switzerland; (11) Pinney Associates, Pittsburgh, PA, U.S.A.
    In the tobacco space, consumer-reported outcome measures (CROM) are essential for understanding motivations, subjective effects, and behavior. Such measures have become particularly important with the advent of candidate modified risk tobacco products ...
  4. CORESTA Meeting, Smoke Science/Product Technology, 2019, Hamburg, STPOST 60

    Can we still observe a net health benefit due to the introduction of modified-risk tobacco products (MRTPs) should the illegal trade in counterfeit cigarettes increase? A model perspective.

    LARROQUE S.; CHARRIERE M.; MEGER M.
    JT International SA, Geneva, Switzerland
    Since 2012 and the publication of the MRTP guidance by the U.S. FDA encouraging the use of computational modelling, many robust dynamic models have been developed that are projecting net health benefits in the whole population after introduction of ...
  5. CORESTA Meeting, Agronomy/Phytopathology, 2017, Santa Cruz do Sul, AP 04

    Contributions to the study of gall wasp occurrence in Eucalyptus woodlots in southern Brazil

    ROESCH F.(1); FEUERBORN M.(1); KOEHLER A.(2); RAUBER M.(2); FARIAS J.(3); WELTER C.A.(3); TEIXEIRA D.S.(3)
    (1) Japan Tobacco International (JTI), Santa Cruz do Sul, RS, Brazil; (2) Universidade de Santa Cruz do Sul (UNISC), Laboratory of Entomology, Santa Cruz do Sul, RS, Brazil; (3) Universidade Federal de Santa Maria (UFSM), Centro de Pesquisas Florestais, Campus Universitário, Santa Maria, RS, Brazil
    Firewood from Eucalyptus spp. is the main source of energy for tobacco curing in South Brazil. Leptocybe invasa Fisher & Lasalle, 2004 (Hymenoptera: Eulophidae) is a gall inducing wasp species that causes damage to eucalyptus plantations and nurseries ...
  6. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 27

    Pharmacokinetics of nicotine following the controlled use of a prototype novel tobacco vapour product

    YUKI D.(1,2); SAKAGUCHI C.(1); KIKUCHI A.(1); FUTAMURA Y.(1)
    (1) Japan Tobacco Inc., R&D Group, Scientific Product Assessment Center, Yokohama, Kanagawa, Japan; (2) JT International S.A., Scientific & Regulatory Affairs, Geneva, Switzerland
    The objective of this clinical study was to investigate the pharmacokinetics of nicotine following the use of a prototype novel tobacco vapour (PNTV) product in comparison to a conventional cigarette (CC1). The study was conducted in Japanese healthy ...
  7. CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 59

    Estimating the filling capacity of cut-rolled expanded stem (CRES) from Visible (Vis)–Near infrared (NIR) spectrum of stem

    SHIMIZU W.(1); ISHIHARA K.(1); YAGASHIRA T.(2)
    (1) Japan Tobacco Inc., Leaf Tobacco Research Center, Tochigi, Japan; (2) JT International Germany GmbH, Trier, Germany
    Filling capacity is an important physical characteristic for evaluating cut-rolled expanded stem (CRES) quality and for designing cigarettes. As presented at the CORESTA Congress 2012, we developed a calibration model between Vis-NIR spectra and filling ...
  8. TSRC, Tob. Sci. Res. Conf., 2017, 71, abstr. 044

    Assessing population health effects of tobacco product use for regulatory compliance: a comparison of available methods

    TEISCHINGER F.(1); POLAND B.(2)
    (1) JT International, Geneva, Switzerland; (2) Certara USA, Menlo Park, CA, USA
    The US FDA encourages use of statistical models to project effects of a new tobacco product on population health, for Modified Risk Tobacco Product Applications (MRTPAs) and Pre-Market Tobacco Applications (PMTAs). We review different methods chosen for ...